MASTERINVEST Kapitalanlage GmbH Invests $2.67 Million in Agilent Technologies, Inc. $A

MASTERINVEST Kapitalanlage GmbH bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, HoldingsChannel reports. The firm bought 20,086 shares of the medical research company’s stock, valued at approximately $2,668,000.

Several other hedge funds also recently added to or reduced their stakes in A. Brighton Jones LLC raised its stake in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares during the last quarter. Jones Financial Companies Lllp grew its stake in shares of Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after acquiring an additional 769 shares during the last quarter. Geneos Wealth Management Inc. grew its stake in shares of Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after acquiring an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its position in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after purchasing an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $273,000.

Agilent Technologies Stock Performance

Shares of A stock opened at $157.60 on Friday. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $163.75. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $44.51 billion, a PE ratio of 31.02, a price-to-earnings-growth ratio of 2.74 and a beta of 1.25. The business has a 50-day simple moving average of $139.76 and a 200-day simple moving average of $126.85.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.84% and a net margin of 19.53%.Agilent Technologies’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period last year, the business earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
• Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
• Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.

Analyst Ratings Changes

Several research firms have weighed in on A. HSBC dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Morgan Stanley lifted their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Bank of America boosted their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $170.33.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.